# Metformin for Rising PSA Remote Trial

> **NCT02376166** · NA · COMPLETED · sponsor: **Matthew Galsky** · enrollment: 15 (actual)

## Conditions studied

- Prostate Cancer

## Interventions

- **DRUG:** Metformin

## Key facts

- **NCT ID:** NCT02376166
- **Lead sponsor:** Matthew Galsky
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-07
- **Primary completion:** 2016-12
- **Final completion:** 2016-12
- **Target enrollment:** 15 (ACTUAL)
- **Last updated:** 2017-12-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02376166

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02376166, "Metformin for Rising PSA Remote Trial". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT02376166. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*